Your browser doesn't support javascript.
loading
Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments.
Castenmiller, S M; de Groot, R; Guislain, A; Monkhorst, K; Hartemink, K J; Veenhof, A A F A; Smit, E F; Haanen, J B A G; Wolkers, M C.
Affiliation
  • Castenmiller SM; Sanquin Blood Supply, Department of Hematopoiesis and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, The Netherlands.
  • de Groot R; Oncode Institute, Utrecht, The Netherlands.
  • Guislain A; Sanquin Blood Supply, Department of Hematopoiesis and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, The Netherlands.
  • Monkhorst K; Oncode Institute, Utrecht, The Netherlands.
  • Hartemink KJ; Sanquin Blood Supply, Department of Hematopoiesis and Landsteiner Laboratory, Amsterdam UMC, Amsterdam, The Netherlands.
  • Veenhof AAFA; Oncode Institute, Utrecht, The Netherlands.
  • Smit EF; Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AvL), Amsterdam, The Netherlands.
  • Haanen JBAG; Department of Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AvL), Amsterdam, The Netherlands.
  • Wolkers MC; Department of Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AvL), Amsterdam, The Netherlands.
Immunooncol Technol ; 15: 100090, 2022 Sep.
Article in En | MEDLINE | ID: mdl-35965844
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Immunooncol Technol Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Immunooncol Technol Year: 2022 Document type: Article